As artificial intelligence rapidly transforms industries, its healthcare applications are reaching a critical inflection point—shifting from conceptual validation to industrial implementation. XUNFEIHEALTH (02506) recently secured a 428 million yuan contract to provide software services for China's National AI Application Pilot Base (Primary Healthcare Direction). This landmark project under the national "AI+" strategy signals that companies with full-stack proprietary technology and scalable application scenarios are evolving from product suppliers to industry infrastructure builders.
The project reflects policy-driven and technological synergies, highlighting XUNFEIHEALTH's three strategic advantages:
1. **Standard-Setting Authority**: The pilot base addresses key challenges in vertical AI implementation—ambiguous technical pathways, lack of standards, and complex scenario validation. As the primary contractor, XUNFEIHEALTH transitions from industry participant to co-architect of national medical AI standards. Its focus on primary healthcare—a policy-priority sector—involves developing a replicable "medical AI operating system" through billion-parameter medical models and high-quality data platforms. This nationwide scalable model positions the company for long-term market leadership through standardized solutions and continuous operations.
2. **Domestic Tech Sovereignty**: In today's geopolitical climate, supply chain security and technological autonomy are critical. XUNFEIHEALTH's Spark Medical Model stands out with its fully domestic computing infrastructure and proprietary tech stack, creating high barriers to entry. Public evaluations show it outperforms international models like GPT-5(high) and DeepSeek V3.2-Exp in medical Q&A, documentation, and specialist consultations—reaching top-tier hospital physician levels. This homegrown technological edge supports sustained valuation premiums.
3. **Business Model Evolution**: Moving beyond one-time software deliveries, XUNFEIHEALTH now offers "Model-as-a-Service" (MaaS) integrating AI, data, and operations. Its flagship "Smart Medical Assistant" serves 250,000 primary care doctors across China, delivering 1.1 billion diagnostic assists while improving electronic record compliance from <40% to 98%. The new project's 21 use cases—from smart diagnosis to chronic disease management—embed AI into core workflows while addressing critical needs like cost control and tiered healthcare. This shift promises recurring revenue streams and enhanced profitability.
As China's healthcare reforms prioritize bridging urban-rural medical gaps through AI, XUNFEIHEALTH's national pilot base role accelerates its commercialization roadmap. With sovereign data assets, core model capabilities, and proven scalability, the company is redefining "AI+Healthcare" value creation—a transformation warranting close market attention.